In addition, it regulates immune responses by upregulating well-known immune checkpoint proteins PD-1 and CTLA-4 on lymphocytes, enhancing CD318+ tumor cell cytotoxicity [12]. The gene discussed is CDCP1; the disease is neoplasm.